Healthcare Sector

ABBV

Market Tracker

$159.37
+1.45
(+0.92%)
4:03 pm
$158.72
-0.65
(-0.41%)
7:59 pm (After Hours)
Next Earnings: (est.) Thu, Apr 27 - Mon, May 01
  • ABBV (Selected)

    AbbVie Inc.

ABBV Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

ABBV Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ABBV Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ABBV Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

ABBV Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ABBV Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
04/21/2023 PUT $146.00 977 +823 +534.42%
05/12/2023 PUT $100.00 319 +319
04/21/2023 CALL $160.00 11,169 +269 +2.47%
04/06/2023 CALL $157.50 404 +192 +90.57%
04/06/2023 PUT $157.50 288 +175 +154.87%
06/16/2023 CALL $165.00 6,857 +151 +2.25%
03/31/2023 PUT $155.00 887 -35 -3.80%
03/31/2023 CALL $155.00 1,418 -38 -2.61%
01/17/2025 CALL $200.00 185 -40 -17.78%
03/31/2023 CALL $160.00 3,062 -52 -1.67%
03/31/2023 CALL $162.50 4,634 -85 -1.80%
03/31/2023 PUT $152.50 275 -99 -26.47%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ABBV Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.98% 52.74M 8.41B
Vanguard 500 Index Fund 2.27% 40.08M 6.39B
SPDR S&P 500 ETF Trust 1.10% 19.51M 3.11B
Fidelity 500 Index Fund 1.10% 19.38M 3.09B
American Mutual Fund Inc 1.02% 18M 2.87B
iShares Core S&P 500 ETF 0.90% 15.88M 2.53B
Vanguard Index-Value Index Fund 0.88% 15.51M 2.47B
Capital Income Builder, Inc. 0.87% 15.3M 2.44B
Washington Mutual Investors Fund 0.83% 14.72M 2.35B
Select Sector SPDR Fund-Health Care 0.83% 14.61M 2.33B

ABBV News

  • These 5 High-Yield Dividend Stocks Should Make Me $3,000 in Passive Income This Year

    04/02 05:50 am

    The Motley Fool

    Read more
  • Could This Drug News Lift AbbVie's Stock?

    04/01 09:15 am

    The Motley Fool

    Read more
  • The Top Healthcare Stocks to Buy With $100

    03/31 10:00 am

    The Motley Fool

    Read more
  • This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie

    03/31 08:50 am

    The Motley Fool

    Read more
  • 2 High-Yielding Dividend Investments to Buy for the Long Haul

    03/30 07:45 am

    The Motley Fool

    Read more
  • Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie

    03/29 02:00 pm

    The Motley Fool

    Read more
  • Better Growth Stock: AbbVie vs. Pfizer

    03/29 07:30 am

    The Motley Fool

    Read more
  • 2 Relatively Safe Dividend Stocks You Won't Regret Owning

    03/28 10:07 am

    The Motley Fool

    Read more
  • This Is the Best Dividend ETF You Can Buy

    03/28 08:13 am

    The Motley Fool

    Read more
  • AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

    03/27 05:45 pm

    Zacks Investment Research

    Read more
  • Is Big Pharma Coming For Your Cannabis Business?

    03/27 02:01 pm

    Benzinga

    Read more
  • The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly

    03/27 07:41 am

    Zacks Investment Research

    Read more
  • I Own 12 High-Yield Dividend Stocks. Here's the Best of the Bunch.

    03/25 05:52 am

    The Motley Fool

    Read more
  • Better Buy: AbbVie vs. Johnson & Johnson

    03/25 05:30 am

    The Motley Fool

    Read more
  • AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs

    03/24 12:56 pm

    Zacks Investment Research

    Read more
  • Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL

    03/24 09:04 am

    Zacks Investment Research

    Read more
  • This Delivery Giant Is A 'Comeback Story' Plus Nike, AbbVie And Oracle: CNBC's 'Final Trades'

    03/24 08:37 am

    Benzinga

    Read more
  • 3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence

    03/24 08:20 am

    The Motley Fool

    Read more
  • 2 High-Yield Dividend Stocks You Won't Regret Buying Right Now

    03/23 10:00 am

    The Motley Fool

    Read more
  • AbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate

    03/23 09:51 am

    Zacks Investment Research

    Read more
  • 3 Things About AbbVie That Smart Investors Know

    03/23 09:15 am

    The Motley Fool

    Read more
  • Use These 3 Strategies to Make $1,000 in Passive Income Per Year

    03/23 06:15 am

    The Motley Fool

    Read more
  • 2 Reasons to Buy AbbVie, and 1 Reason to Sell

    03/23 05:30 am

    The Motley Fool

    Read more
  • Here's What is Driving Amgen (AMGN) Stock's Outperformance

    03/22 05:51 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know

    03/20 05:45 pm

    Zacks Investment Research

    Read more
  • Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?

    03/20 06:20 am

    Zacks Investment Research

    Read more
  • Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?

    03/20 06:20 am

    Zacks Investment Research

    Read more
  • 4 Top Value Stock ETFs for Long-Term Wealth Building

    03/19 06:31 am

    The Motley Fool

    Read more
  • 2 Growth Stocks to Buy Before the Bull Market Arrives

    03/16 08:30 am

    The Motley Fool

    Read more
  • The Zacks Analyst Blog Highlights AbbVie, NextEra Energy, ConocoPhillips, Canadian Pacific Railway and Intercontinental Exchange

    03/14 08:46 am

    Zacks Investment Research

    Read more
  • Oracle, AbbVie And This Gold Fund: CNBC's 'Final Trades'

    03/14 08:37 am

    Benzinga

    Read more
  • 5 Forever Dividend Stocks

    03/14 07:00 am

    The Motley Fool

    Read more
  • AbbVie (ABBV) Gains As Market Dips: What You Should Know

    03/13 05:45 pm

    Zacks Investment Research

    Read more
  • Top Research Reports for AbbVie, NextEra Energy & ConocoPhillips

    03/13 01:10 pm

    Zacks Investment Research

    Read more
  • The Near-Perfect Portfolio: Sleep Well During Turbulent Times

    03/11 10:00 am

    Seeking Alpha

    Read more
  • 3 No-Brainer Dividend Stocks to Buy in March

    03/11 07:14 am

    The Motley Fool

    Read more
  • Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

    03/10 10:00 am

    Zacks Investment Research

    Read more
  • Zacks Investment Ideas feature highlights: Coca-Cola Company, AbbVie and Exxon Mobil

    03/10 06:00 am

    Zacks Investment Research

    Read more
  • Reap Monthly Income With This Combination of 3 Stocks

    03/09 03:29 pm

    Zacks Investment Research

    Read more
  • Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?

    03/09 07:20 am

    Zacks Investment Research

    Read more
  • 3 Surefire Stocks That Are Screaming Buys in March

    03/09 07:07 am

    The Motley Fool

    Read more
  • 3 High-Yield Dividend Stocks to Buy Before the Next Bull Rally

    03/09 06:41 am

    The Motley Fool

    Read more
  • Is It Too Late to Buy AbbVie Stock?

    03/09 06:30 am

    The Motley Fool

    Read more
  • My Portfolio February Update: 4 Buys, 1 Sale

    03/09 04:28 am

    Seeking Alpha

    Read more
  • Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?

    03/07 07:20 am

    Zacks Investment Research

    Read more
  • 2 Top Dividend Kings to Buy for the Long Haul

    03/04 10:53 am

    The Motley Fool

    Read more
  • 2 High-Yield Dividend Stocks to Buy in March

    03/04 07:27 am

    The Motley Fool

    Read more
  • Nearing retirement? Here’s how to transition your portfolio from growth to income.

    03/03 06:26 pm

    MarketWatch

    Read more
  • Could This Humira Biosimilar Be a Winner for Amgen?

    03/03 07:00 am

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: